首页> 外文期刊>Clinical autonomic research: Official journal of the Clinical Autonomic Research Society >Results of endoscopic thoracic sympathectomy (ETS) on hyperhidrosis, facial blushing, angina pectoris, vascular disorders and pain syndromes of the hand and arm
【24h】

Results of endoscopic thoracic sympathectomy (ETS) on hyperhidrosis, facial blushing, angina pectoris, vascular disorders and pain syndromes of the hand and arm

机译:内镜下胸交感神经切除术(ETS)治疗多汗症,面部红斑,心绞痛,血管疾病和手和手臂疼痛综合征的结果

获取原文
获取原文并翻译 | 示例
       

摘要

Endoscopic thoracic sympathectomy (ETS) has gained increasing popularity due to its minimally invasive character. Despite the simplicity of the procedure, non-surgical options should always be considered as the first line of treatment. The complication risk of ETS is low but side effects, primarily compensatory sweating (CS) of mainly the trunk, may be severe enough to cause regret of the procedure. The risk/benefit ratio should always be discussed with the patient. Severe palmar hyperhidrosis and facial blushing respond very well to ETS with a high patient satisfaction rate. Facial hyperhidrosis is effectively treated with ETS, but is associated with a high risk for severe CS. Axillary hyperhidrosis is best treated by means other than ETS. The use of ETS for pain syndromes, vascular insufficiency and angina pectoris is not well supported by scientific evidence, making careful patient selection mandatory.
机译:内窥镜胸交感神经切除术(ETS)由于其微创性而越来越受欢迎。尽管操作简单,但始终应将非手术选择视为治疗的第一线。 ETS的并发症风险较低,但副作用(主要是躯干的主要代偿性出汗(CS))可能严重到足以引起手术遗憾。风险/收益比应始终与患者讨论。严重的手掌多汗症和面部红斑对ETS的反应非常好,患者满意度很高。 ETS可有效治疗面部多汗症,但伴有严重CS的高风险。腋窝多汗症最好用ETS以外的方法治疗。科学证据不能很好地支持将ETS用于疼痛综合征,血管供血不足和心绞痛,因此必须谨慎选择患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号